ADIL
Adial Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.52M
P/E Ratio
—
EPS
$-4.89
Beta
1.27
52W High
$18.90
52W Low
$1.31
50-Day MA
$1.85
200-Day MA
$5.20
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adial Pharmaceuticals Inc
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-7.70M |
| Operating Margin | 0.00% |
| Return on Equity | -265.90% |
| Return on Assets | -110.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.46 |
| Price-to-Book | 1.74 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.19M |
| Float | $1.93M |
| % Insiders | 5.25% |
| % Institutions | 14.45% |
Historical Volatility
HV 10-Day
177.54%
HV 20-Day
168.81%
HV 30-Day
146.15%
HV 60-Day
113.55%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026